ClinicalTrials.gov
public full text
Public Domain
Tirapazamine Plus Cyclophosphamide in Treating Children With Refractory Solid Tumors
Phase I trial to study the effectiveness of tirapazamine plus cyclophosphamide in treating children who have refractory solid tumors. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk Neuroblastoma#860745
- Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia#810492
- Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer#1173979
- Combination Chemotherapy in Treating Patients With Soft Tissue Sarcoma#873637
- Evaluate the Effect of Tirazamine on Primary Liver Cancer.#875266
Record · ID 1369654
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive